Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jul;42(1):52–57. doi: 10.1038/bjc.1980.202

Malignant melanoma: sex differences in survival after evidence of distant metastasis.

F Rampen
PMCID: PMC2010477  PMID: 7426329

Abstract

Survival data of 106 males and 110 females with disseminated malignant melanoma, recorded between 1956 and 1975, were reviewed. Survival after first evidence of distant metastasis was significantly longer in women than in men (P = 0.02). There was no difference in survival after occurrence of distant metastasis between pre- and postmenopausal women, nor between parous and nulliparous women. However, there was a clear female superiority of premenopausal women over males less than or equal to 50 years and, to a lesser extent, of postmenopausal women over males > 50 years. It is concluded that endocrine factors enhance melanoma activity in the male patient. The suggestion that malignant melanoma is "testosterone-dependent" seems justifiable. A possible explanation is given for the general experience that women with melanoma show a more favourable response to chemotherapy than men.

Full text

PDF
52

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN E. P. Malignant melanoma; spontaneous regression after pregnancy. Br Med J. 1955 Oct 29;2(4947):1067–1067. doi: 10.1136/bmj.2.4947.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clark W. H., Jr, Ainsworth A. M., Bernardino E. A., Yang C. H., Mihm C. M., Jr, Reed R. J. The developmental biology of primary human malignant melanomas. Semin Oncol. 1975 Jun;2(2):83–103. [PubMed] [Google Scholar]
  3. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  4. Comis R. L., Carter S. K. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev. 1974 Dec;1(4):285–304. doi: 10.1016/s0305-7372(74)80020-4. [DOI] [PubMed] [Google Scholar]
  5. Fisher R. I., Neifeld J. P., Lippman M. E. Oestrogen receptors in human malignant melanoma. Lancet. 1976 Aug 14;2(7981):337–339. doi: 10.1016/s0140-6736(76)92592-7. [DOI] [PubMed] [Google Scholar]
  6. Friedman M. A., Hoffman P. G., Jones H. W. The clinical value of hormone receptor assays in malignant disease. Cancer Treat Rev. 1978 Dec;5(4):185–194. doi: 10.1016/s0305-7372(78)80012-7. [DOI] [PubMed] [Google Scholar]
  7. GEORGE P. A., FORTNER J. G., PACK G. T. Melanoma with pregnancy. A report of 115 cases. Cancer. 1960 Jul-Aug;13:854–859. doi: 10.1002/1097-0142(196007/08)13:4<854::aid-cncr2820130431>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  8. Gilchrist K. W., Gilbert E., Metter G., Powers D. Importance of microscopic vascular invasion in primary cutaneous malignant melanoma. Surg Gynecol Obstet. 1977 Oct;145(4):559–561. [PubMed] [Google Scholar]
  9. Hersey P., Morgan G., Stone D. E., McCarthy W. H., Milton G. W. Previous pregnancy as a protective factor against death from melanoma. Lancet. 1977 Feb 26;1(8009):451–452. doi: 10.1016/s0140-6736(77)91943-2. [DOI] [PubMed] [Google Scholar]
  10. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966 Mar;50(3):163–170. [PubMed] [Google Scholar]
  11. Nathanson L., Hall T. C., Farber S. Biological aspects of human malignant melanoma. Cancer. 1967 May;20(5):650–655. doi: 10.1002/1097-0142(1967)20:5<650::aid-cncr2820200512>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  12. PACK G. T., SCHARNAGEL I. M. The prognosis for malignant melanoma in the pregnant woman. Cancer. 1951 Mar;4(2):324–334. doi: 10.1002/1097-0142(195103)4:2<324::aid-cncr2820040218>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  13. Sadoff L., Winkley J., Tyson S. Is malignant melanoma an endocrine-dependent tumor? The possible adverse effect of estrogen. Oncology. 1973;27(3):244–257. doi: 10.1159/000224736. [DOI] [PubMed] [Google Scholar]
  14. Schmoeckel C., Braun-Falco O. Prognostic index in malignant melanoma. Arch Dermatol. 1978 Jun;114(6):871–873. [PubMed] [Google Scholar]
  15. Shaw H. M., Milton G. W., Farago G., McCarthy W. H. Endocrine influences on survival from malignant melanoma. Cancer. 1978 Aug;42(2):669–677. doi: 10.1002/1097-0142(197808)42:2<669::aid-cncr2820420238>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  16. WHITE L. P., LINDEN G., BRESLOW L., HARZFELD L. Studies on melanoma. The effect of pregnancy on survival in human melanoma. JAMA. 1961 Jul 29;177:235–238. doi: 10.1001/jama.1961.03040300007002. [DOI] [PubMed] [Google Scholar]
  17. WHITE L. P. Studies on melanoma. II. Sex and survival in human melanoma. N Engl J Med. 1959 Apr 16;260(16):789–797. doi: 10.1056/NEJM195904162601601. [DOI] [PubMed] [Google Scholar]
  18. WHITE L. P. The role of natural resistance in the prognosis of human melanoma. Ann N Y Acad Sci. 1963 Feb 15;100:115–122. doi: 10.1111/j.1749-6632.1963.tb57116.x. [DOI] [PubMed] [Google Scholar]
  19. Weiss N. S., Flannery J. T. The relationship of marital status to survival from melanoma. Cancer. 1978 Jul;42(1):296–298. doi: 10.1002/1097-0142(197807)42:1<296::aid-cncr2820420144>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES